California Public Employees Retirement System
ELVN icon

California Public Employees Retirement System’s Enliven Therapeutics ELVN Stock Holding History

California Public Employees Retirement System’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,995
Closed -$135K – 1975
2021
Q1 		$135K Sell
3,995
-374
-9% -$19K ﹤0.01% 3433
2020
Q4 		$385K Sell
4,369
-5,480
-56% -$460K ﹤0.01% 3058
2020
Q3 		$801K Buy
9,849
+200
+2% +$18K ﹤0.01% 2443
2020
Q2 		$1.07M Buy
+9,649
New +$1.08M ﹤0.01% 2189

Other funds holding ELVN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System's ELVN Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Enliven Therapeutics (ELVN) in Q2 2021, closing a stake of 3,995 shares — an estimated $135K sold.

California Public Employees Retirement System first reported a position in ELVN in Q2 2020 and held it in 4 quarters. The position peaked at $1.07M in Q2 2020. 31 funds tracked by Wall St. Rank hold ELVN as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Enliven Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 3,995 Enliven Therapeutics shares in Q2 2021, an estimated $135K.
  • California Public Employees Retirement System first reported a position in Enliven Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Enliven Therapeutics position peaked at $1.07M in Q2 2020.
  • 31 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.